Treco Douglas A (CIK 1688192) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-08-08). Recent activity: Buy CRSP (20,000 shares), Sell INZY (43,861 shares), Buy INZY (2,815 shares), Buy INZY (25,000 shares), Sell INZY (8,819 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-08 | CRISPR Therapeutics AG (CRSP) | Director | Buy | 20,000 | $1.1M |
| 2025-07-03 | Inozyme Pharma, Inc. (INZY) | CEO & Chairman | Sell | 43,861 | $175,444 |
| 2025-06-27 | Inozyme Pharma, Inc. (INZY) | CEO & Chairman | Buy | 2,815 | $2,083 |
| 2025-04-03 | Inozyme Pharma, Inc. (INZY) | CEO & Chairman | Buy | 25,000 | $0 |
| 2025-04-03 | Inozyme Pharma, Inc. (INZY) | CEO & Chairman | Sell | 8,819 | $7,849 |
Source: SEC Form 4 filings · as of 2025-08-08